Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • June 2020
  • Case
  • HBS Case Collection

Breakthroughs at Blueprint Medicines

By: Richard G. Hamermesh, Kathy Giusti and Susie L. Ma
  • Format:Print
  • | Language:English
  • | Pages:17
ShareBar

Abstract

Precision medicine company Blueprint Medicines was building a successful track record for bringing drug therapies to market 40% faster than average. The company had spent $40 million dollars and two years building a compound library that became its drug development engine. Blueprint’s drug development strategy was twofold—it focused on creating a single drug compound for multiple disease indications, while at the same time developing drugs to track a disease through its progression. The company’s goal was to become a fully integrated biopharmaceutical company that could move from drug discovery to development to marketing. But it was increasingly challenging to prioritize and manage programs, personnel and partnerships.

Keywords

Precision Medicine; Cancer; Biotechnology; Drug Development; Strategy; Expansion; Science; Genetics; Information Technology; Entrepreneurship; Organizational Culture; Management; Growth and Development; Pharmaceutical Industry; United States; Cambridge; Massachusetts

Citation

Hamermesh, Richard G., Kathy Giusti, and Susie L. Ma. "Breakthroughs at Blueprint Medicines." Harvard Business School Case 820-001, June 2020.
  • Educators
  • Purchase

About The Author

Richard G. Hamermesh

→More Publications

More from the Authors

    • March 2022
    • Faculty Research

    Unilever: Remote Work in Manufacturing

    By: Prithwiraj Choudhury and Susie L. Ma
    • February 2022
    • Faculty Research

    Paul Polman

    By: Elizabeth A. Keenan, Youngme Moon and Susie Ma
    • January 17, 2022
    • Harvard Business Review (website)

    Reducing Racial Disparities in Cancer Outcomes

    By: Kathy Giusti and Richard G. Hamermesh
More from the Authors
  • Unilever: Remote Work in Manufacturing By: Prithwiraj Choudhury and Susie L. Ma
  • Paul Polman By: Elizabeth A. Keenan, Youngme Moon and Susie Ma
  • Reducing Racial Disparities in Cancer Outcomes By: Kathy Giusti and Richard G. Hamermesh
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College